Oxygen Costs of the Incremental Shuttle Walk Test in Cardiac Rehabilitation Participants: An Historical and Contemporary Analysis.

Buckley, John P; Cardoso, Fernando M F; Birkett, Stefan T; Sandercock, Gavin R H · Sports Med · 2016

prospective_cohort · Level II

Where this comes from

Abstract

The incremental shuttle walk test (ISWT) is a standardised assessment for cardiac rehabilitation. Three studies have reported oxygen costs (VO<sub>2</sub>)/metabolic equivalents (METs) of the ISWT. In spite of classic representations from these studies graphically showing curvilinear VO<sub>2</sub> responses to incremented walking speeds, linear regression techniques (also used by the American College of Sports Medicine [ACSM]) have been used to estimate VO<sub>2</sub>. The two main aims of this study were to (i) resolve currently reported discrepancies in the ISWT VO<sub>2</sub>-walking speed relationship, and (ii) derive an appropriate VO<sub>2</sub> versus walking speed regression equation. VO<sub>2</sub> was measured continuously during an ISWT in 32 coronary heart disease [cardiac] rehabilitation (CHD-CR) participants and 30 age-matched controls. Both CHD-CR and control group VO<sub>2</sub> responses were curvilinear in nature. For CHD-CR VO<sub>2</sub> = 4.4e<sup>0.23 × walkingspeed (km/h)</sup>. The integrated area under the curve (iAUC) VO<sub>2</sub> across nine ISWT stages was greater in the CHD-CR group versus the control group (p < 0.001): CHD-CR = 423 (±86) ml·kg<sup>-1</sup>·min<sup>-1</sup>·km·h<sup>-1</sup>; control = 316 (±52) ml·kg<sup>-1</sup>·min<sup>-1</sup>·km·h<sup>-1</sup>. CHD-CR group vs. control VO<sub>2</sub> was up to 30 % greater at higher ISWT stages. The curvilinear nature of VO<sub>2</sub> responses during the ISWT concur with classic studies reported over 100 years. VO<sub>2</sub> estimates for walking using linear regression models (including the ACSM) clearly underestimate values in healthy and CHD-CR participants, and this study provides a resolution to this when the ISWT is used for CHD-CR populations.

Medical subject headings